Imperial and CNRS Launch Joint Lab for Metabolism Research
New 'Antoine Lavoisier' International Research Laboratory will use AI and multiscale biology to advance global health understanding.
By Daniel Okafor
••3 min read
AI
Generic image of a DNA helix intertwined with abstract glowing lines representing artificial intelligence, set against a blurred background of a modern laboratory with scientific equipment.
Imperial College London and France's National Centre for Scientific Research (CNRS) have officially launched the 'Antoine Lavoisier' International Research Laboratory in Multiscale Metabolism, aiming to enhance the understanding of human metabolism and improve global health outcomes.
The new laboratory will employ advanced techniques such as artificial intelligence (AI), machine learning, and multiscale biology to study metabolism from a subcellular level up to large populations. This research is intended to lead to better health outcomes for conditions including obesity, diabetes, cardiometabolic diseases, associated cancers, neurodegenerative diseases like Alzheimer’s and Parkinson’s, and cerebrovascular diseases such as dementia.
This marks Imperial's third International Research Laboratory with the CNRS, following the establishment of the Ayrton-Bleriot Engineering Lab (ABEL) and the mathematics laboratory ‘Abraham de Moivre’. The launch was celebrated with an event titled 'Metabolism across scales: AI and the future of global health', which gathered researchers, health leaders, policymakers, and funders.
“
"The lab will bring together leading researchers from the CNRS and Imperial to advance our understanding of metabolism, from the molecular to whole organism level, with the potential to transform how we approach human health and disease. The lab is also a demonstration of how international scientific collaboration can shape important discussions with policymakers and provide a direct pathway to impact."
“
"I strongly believe by fostering international cooperation we have a chance to achieve the goals we set. The idea of encouraging scientists to build bridges between disciplines is at the core of the strategic partnerships we are developing at the CNRS – our International Research Centres. The topic that will be investigated by the Antoine Lavoisier Laboratory perfectly fits with the overall objective of the CNRS-Imperial International Research Centre for Transformational Science and Technology."
Directors of the lab, Professor Mark Thursz and Professor Marc-Emmanuel Dumas, provided an overview of the laboratory's scientific objectives. They participated in a panel discussion with Dr Catherine Postic, President of the Scientific Council of the French Diabetes Association, exploring the role of AI and multiscale biology in metabolic disease research and treatment. The discussion highlighted how combining clinical data and machine learning across the UK and France could accelerate progress against various health conditions.
A new Marie Skłodowska-Curie Actions (MSCA) COFUND grant was also announced by Professor Sandrine Heutz and Dr Emmanuel Brouillet to support early-career researcher mobility and training within the partnership. This EU-funded programme will involve several international universities, including the University of Arizona and the University of Tokyo.
The collaboration underscores Imperial's dedication to international scientific partnerships. The CNRS is Imperial's leading European collaborator, with nearly 3,000 joint publications in the past five years. The International Research Centre for Transformational Science and Technology, launched in 2022, further strengthens this relationship, focusing on research for sustainability, connectivity, and health engineering.